A Systems Biology Approach to Discovery and Validation of MicroRNA Signature Health Risks Associated with the Space...

Area of Science:

• Space biology and biomedicine
• Molecular biology and genetics
• Human health in extreme environments

Background:

• Space environment exposure induces significant physiological and molecular changes in living organisms.
• Noncoding RNAs (ncRNAs), especially microRNAs (miRNAs), are understudied in space biomedicine despite their regulatory roles.
• Spaceflight poses systemic health risks, highlighting the need to understand molecular regulators like miRNAs.

Purpose of the Study:

• To identify and validate a signature of microRNAs (miRNAs) associated with spaceflight exposure.
• To explore miRNAs as potential biomarkers and therapeutic targets for spaceflight-induced health risks.
• To advance understanding of molecular mechanisms underlying space biology.

Main Methods:

• Utilized transcriptomic data and pathway analyses to identify key genes affected by spaceflight.
• Predicted upstream regulatory miRNAs based on identified driver genes to form a candidate signature.
• Employed droplet digital PCR (ddPCR) for precise and absolute quantification of miRNA expression in validation studies.

Main Results:

• Successfully identified candidate miRNAs as potential regulators of spaceflight-induced physiological states.
• Validated specific miRNA expression profiles using ddPCR, enabling accurate quantification.
• Demonstrated ddPCR's advantage over conventional PCR for miRNA expression analysis in spaceflight research.

Conclusions:

• MicroRNAs are critical regulators of biological responses to spaceflight.
• A validated miRNA signature can serve as a biomarker for spaceflight exposure.
• Targeting specific miRNAs offers a promising strategy for countermeasures against spaceflight-induced health risks.
• This approach can be broadly applied to identify miRNA signatures for various diseases and stressors.